Resources

In clinics and communities, thousands of health workers have been trained to safely administer the self-injectable contraceptive subcutaneous DMPA (DMPA-SC)—including support for women learning to self-inject. Visit the DMPA-SC Resource Library to access training and supportive supervision materials to equip facility- and community-based family planning providers in the public and private sector.For more information, contact FPoptions@path.org or sign up for our newsletters.

Since 2016, PATH has been supporting the implementation of the U.S. President's Emergency Plan for AIDS Relief's DREAMS programming to keep AGYW HIV-free with a holistic package of health, economic empowerment, education, and social services. After DREAMS enrollees receive all of their age-specific services, they graduate and exit the project. Despite having participated in financial capability and entrepreneurship training, many young women still lack the networks, opportunities, and capital to earn a living and become financially stable.The PATH-led Chak a Chaka project provides DREAMS graduates with opportunities to save, build, and employ entrepreneurial skills and create supportive and sustainable networks that protect their health and wellbeing, and that of their children and families. This factsheet provides additional details on the Chak a Chaka project and its successes to date.

In collaboration with global stakeholders, the PATH Diagnostics program conceptualizes, develops, commercializes, and ensures access to quality-assured diagnostic technologies that guide clinical decision-making, support surveillance, and inform health policies in low- and middle-income countries (LMIC). We combine market access capabilities with broad technical expertise in developing and scaling up innovative solutions to the world’s most pressing health challenges.

PATH’s Diagnostics program facilitates the generation of actionable evidence to advance diagnostic solutions that are context appropriate, user-driven, and perform as required. Our evidence-generation capabilities are critical to rigorously evaluating products before advancing their development and ensuring that useful, high-quality, fit-for-purpose products enter the market.

India recorded more than 1.7 million new cases of HIV in the last 10 years between 2011 and 2021. To attain India's commitment to achieve the United Nations Programme on HIV/AIDS (UNAIDS) 95-95-95 targets by 2030 and end the AIDS epidemic as a public health threat by 2030 in line with Sustainable Development Goals, India needs to strengthen the prevention-testing-treatment-care continuum.Leveraging the experience of STAR phases 1 and 2, PATH has been implementing the STAR Phase 3 project in India. The implementation study was conducted to demonstrate the feasibility and acceptability of HIVST across specific populations. The study was conducted in 14 high HIV prevalence states of India through five service delivery models. A detailed analysis plan was developed to examine and review the findings from the study. As the study concluded in June 2022, the process of data analysis was conducted to understand the information collected from the study participants.PATH has developed high-quality, reliable, and ready-reference knowledge products like the summary report and a compendium of success stories on various interventions, lessons learnt and key takeaways of the HIV Self Testing project in India.